A presentation to: Meeting name Date

Slides:



Advertisements
Similar presentations
Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women: a Cochrane review Clinical.
Advertisements

CATARACT ASSESSMENT Cataract: opacity of the lens Population at risk: greater than 70 years old S&S: blurred vision.
Enhanced recovery meta-analysis Kirsty Cattle Research Registrar.
Anterior Chamber Depth, Iridocorneal Angle Width, and Intraocular Pressure Changes After Phacoemulsification: Narrow vs Open Iridocorneal Angles Huang.
E. McLaughlin, P. D. Chakravarty, D. Whittaker, E. Cowan, K. Xu, E. Byrne, D.M. Bruce, J. A. Ford University of Aberdeen.
Will my Glaucoma patient lose vision ?
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Trabeculectomy for Open-Angle Glaucoma Takihara Y, Inatani M, Ogata-Iwao M, et.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
Community wide interventions for physical activity Clinical
Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,
Mr. A. Waldock MD BMed Sci (Hons) BM BS FRCOphth Consultant Ophthalmic Surgeon Ophthalmology Training Programme Director, East of England Deanery.
Summary of “A randomized trial of standard versus intensive blood-pressure control” The SPRINT Research Group, NEJM, DOI: /NEJMoa Downloaded.
Surgical Outcomes In Children With Primary Childhood Glaucoma
iStent with phacoemulsification, n=50
Psychosocial Combined with Agonist Maintenance Treatments versus Agonist Maintenance Treatments Alone for Treatment of Opioid Dependence (Review) Amato,
COMBINED PHACOEMULSIFICATION AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION
The SPRINT Research Group
Tulsi Changulani 1,*, Jenny Bo 2, Mei-Ling Cheng 1, Andrew Tatham 1
LONG-TERM RESULTS OF DEEP SCLERECTOMY IN NORMAL-TENSION GLAUCOMA
Abstract # Rates of Complications and Required Additional Surgical Interventions after Surgical and Nonsurgical Treatment in Lumbar Spondylosis:
Lasers in Glaucoma: Meta analysis
A presentation to: Meeting name Date
Ann Intern Med. 2009;150(11): doi: / Figure Legend:
Fatimah Al-Ani 1,2,. MD MRCP, Jose Maria Bastida Bermejo3,
A presentation to: Meeting name Date
Preoperative Characteristics
Frolov Mikhail, Dushina Galina
Health-care interactions and placebo effects:
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Kyoto Prefectural University of Medicine
Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES study Jelena Savović1, Becky Turner2, David.
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Clinical study of open angle glaucoma surgery treatment trough deep slerectomy with T-Flux NV implant: three years follow-up Dr. Marco Rossi Dr Michele.
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy  Mrittika Sen,
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Ophthalmology Glaucoma
Micropulse Transscleral Cyclophotocoagulation
Yoga treatment for chronic non-specific low back pain
Presentation transcript:

A presentation to: Meeting name Date Device-modified trabeculectomy for glaucoma Xue Wang, Rabeea Khan, Anne Coleman Issue 12, 2015 A presentation to: Meeting name Date

Table of Contents 01 Background 02 Types of studies 03 Key results 04 Tables (Risk of Bias/Forest Plots) 05 Conclusions 06 Acknowledgements

01: Background “The main treatment for glaucoma aims to reduce intraocular pressure (IOP)” “IOP can be lowered with medications, and laser or incisional surgeries” “Trabeculectomy is the most common incisional surgical procedure to treat glaucoma.” Objective: To assess relative effectiveness of the use of different devices as adjuncts to trabeculectomy compared with standard trabeculectomy in eyes with glaucoma

02: Types of studies Participants 33 randomized controlled trials; 1542 participants Interventions Device plus trabeculectomy (Ex-PRESS, Ologen, amniotic membrane, E-PTFE, Gelfilm) VERSUS Trabeculectomy alone

03: Key results “…use of Ex-PRESS compared with trabeculectomy alone may be associated with a slightly lower IOP at one year.” MD -1.58 mm Hg, 95% CI -2.74 to -0.42 “Cataract surgery and hyphema may be less frequent in the Ex-PRESS group than in the trabeculectomy-alone group…” RR 0.32, 95% CI 0.14 to 0.74

03: Key results (continued) “…use of Ologen compared with trabeculectomy alone is associated with slightly higher IOP at one year.” MD 1.40 mm Hg, 95% CI -0.57 to 3.38 “…use of amniotic membrane with trabeculectomy may be associated with lower IOP at one year compared with trabeculectomy alone.” MD -3.92 mm Hg, 95% CI -5.41 to -2.42

03: Key results (continued) “…use of amniotic membrane with trabeculectomy may be associated with lower IOP at one year compared with trabeculectomy alone.” MD -3.92, 95% CI -5.41 to -2.42; 356 eyes “The report from the only E-PTFE study (60 eyes) showed no important differences for postoperative IOP at one year (MD - 0.44 mm Hg, 95% CI -1.76 to 0.88) between the trabeculectomy + E-PTFE versus the trabeculectomy-alone groups.”

04: Tables Postoperative IOP at one year

04: Tables Postoperative IOP at one year

04: Tables – IOP at one year

04: Tables Post-operative IOP at one year

05: Conclusions “Overall, the use of devices with standard trabeculectomy may help with greater IOP reduction at one-year follow-up than trabeculectomy alone.” “The evidence that these devices are as safe as trabeculectomy alone is unclear.”

06: Acknowledgements Cochrane Eyes and Vision US Satellite, funded by the National Eye Institute, National Institutes of Health Cochrane Eyes and Vision Editorial Base, funded by the UK National Health Service Research and Development Programme Xue Wang, Rabeea Khan, Anne Coleman Review citation Wang X, Khan R, Coleman A. Device-modified trabeculectomy for glaucoma. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No.: CD010472. DOI: 10.1002/14651858.CD010472.pub2.